Dr Lisa Sammaritano shares evidence-based strategies for pregnancy planning, contraception, and reproductive counseling in women with systemic lupus erythematosus.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002129. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases https://pubmed.ncbi.nlm.nih.gov/32090480/

EULAR Recommendations for Use of Antirheumatic Drugs in Reproduction, Pregnancy, and Lactation: 2024 Update https://pubmed.ncbi.nlm.nih.gov/40287311/

Contraception in Patients With Rheumatic Disease https://pubmed.ncbi.nlm.nih.gov/28390561/

Combined Oral Contraceptives in Women With Systemic Lupus Erythematosus https://pubmed.ncbi.nlm.nih.gov/16354891/

Pregnancy Outcomes Between Pregnant Systemic Lupus Erythematosus Patients With Clinical Remission and Those With Low Disease Activity: A Comparative Study https://pubmed.ncbi.nlm.nih.gov/36589601/

Prevention of Preeclampsia With Aspirin https://pubmed.ncbi.nlm.nih.gov/32835720/

Adverse Effects of Prenatal Dexamethasone Exposure on Fetal Development https://pubmed.ncbi.nlm.nih.gov/35367871/

Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies https://pubmed.ncbi.nlm.nih.gov/37947364/

The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial https://pubmed.ncbi.nlm.nih.gov/15968009/

Fezolinetant Prescribing Information https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216578s000lbl.pdf